Skip to content

Ex Vivo Exploratory Analysis in Healthy Full-term Infants

Ex Vivo Exploratory Analysis in Healthy Full-term Infants

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01573884
Enrollment
54
Registered
2012-04-10
Start date
2011-09-30
Completion date
2012-02-29
Last updated
2012-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Infant and Mother Pairs

Brief summary

* Exploratory analyses of the immune response in a ex vivo culture system * Characterization of the composition of maternal milk and infant urine

Interventions

None listed

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Days
Healthy volunteers
Yes

Inclusion criteria

* Infant or infant-mother pair in good health * Infant or infant-mother pair is from smoke-free home * Infant is a singleton, full term * birth weight was \> 2490 g * Between 0 and 17 days of age at enrollment * Human milk fed infants must have been exclusively human milk-fed since birth; formula fed infants must have received Similac Advance or Similac Sensitive since birth * Parents confirm their intention not to administer vitamin or mineral supplements (excluding vitamin or mineral supplements containing vitamin D), solid foods or juices to their infant from enrollment throughout the study

Exclusion criteria

* An adverse maternal, fetal or infant medical history, including gestational diabetes that is thought by the investigator to have potential for effects on tolerance, growth, and/or development. * Infant has been treated with antibiotics * Participation in another study -

Design outcomes

Primary

MeasureTime frame
Viral load in cell cultures14 days

Secondary

MeasureTime frame
Changes in viral load and cytokine profiles14 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026